Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/534
Title: Golimumab, a Human Anti–Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1‐Year and 2‐Year Clinical, Radiologic, and Physical Function Findings of a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study
Authors: Park, Won
Amante, Eric
Fleischmann, Roy M
Emery, Paul
Strusberg, Ingrid
Durez, Patrick
Pons‐Estel, Bernardo
Churchill, Melvin
Nash, Peter
Doyle, Mittie K
Issue Date: 2013
Source: 65, (11), 2013, p. 1732-1742
Pages: 1732-1742
Journal: Arthritis Care & Research
Type: Article
Appears in Sites:Sunshine Coast HHS Publications

Show full item record

Page view(s)

50
checked on Mar 25, 2025

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.